Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

Clinical trial NCT01245179 · RECRUITING

Trial details

NCT number: NCT01245179
Sponsor: Abdullah Kutlar
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2010-11-01
Primary completion: 2026-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.